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ABSTRACT  
In present era of science, facts established by proofs derived after careful 
investigations, observations and experiments and supported by accurate 
data can convince the people about validity of the statement. Modern 
medical science achieved tremendous advance in past few centuries with 
the help of experimental research. An experimental pharmacological study 
of Saptacakra and Puga (Ashodita and Asuddha) in alloxan (120 mg/kg) 
induced diabetic rats was done at Pharmacology Laboratory of Sree 
Vidyanikkethan Pharmacy College, Tirupati. The diabetic rats were 
divided into six groups [Control group (NC), Diabetic control group (ALX), 
Ashodita Puga group (ALX + ACP), Saptacakra group (ALX + SRP), Suddha 
Puga group (ALX + BACP) and Combination of Saptackara and Suddha 
Puga group (ALX + SRBACP)] with 6 animals in each groups and treated 
with 450 mg/kg of respective drugs. Blood sugar level and the serum lipid 
profiles such as total cholesterol, Phospholipids, triglycerides, LDL, V-LDL 
and HDL investigations and histopathological studies on liver and 
pancreases tissues were carried out in normal and diabetic rats. 
 The combination of both Saptacakra and Suddha Puga (SRBACP) 
shows 47.02% decrease in blood sugar level. It is extremely significant (p< 
0.001), though all the other groups show reduction in blood sugar level. 
Reduction in lipid profile was best noticed in BACP group; in particular 
reduction in triglycerides and improvement HDL was in combination 
group. Hepatoprotective action and regeneration of islets of langherans 
was best seen in combination group. 
INTRODUCTION 
The experimental research are done on lower 
animals to study normal and abnormal conditions and 
for artificially producing diseases and then to study the 
effect of trial drugs, natural course of the disease, 
changes produced in the organs and tissues, etc. as a 
result of the actions of etiological factor or the action of 
the trial drug. 
Pharmacology is a subsidiary subject of modern 
medicine. It deals with the action of drugs on the body. 
Dynamics of drug action is it’s another name. That is 
why it has got a synonym “Pharmacodynamics”. Special 
feature of basic pharmacology is that most of its studies 
are based on animal experiments. The ultimate object 
of course is to make an attempt to correlate the results 
obtained in basic pharmacological study with 
therapeutics or remedial measure employed in the 
treatment of disease. 
In the recent few years Saptacakra and Puga has 
drawn the attention of scientist on various activities in 
human body especially in the field of Diabetes Mellitus 
i.e., Madhumeha. So it was thought to do 
comprehensive literary study of these drugs in 
Madhumeha (Diabetes Mellitus). The literary review of 
the Puga and Saptacakra was started right from the 
Vedas up to recent research works to obtain thorough 
knowledge of drug. The literary reviews of the drugs 
are mentioned below. 
Saptacakra is the main ingredient in Yogas like 
‘Nisakatakadikvatha, Katakakhadiradi kvatha, 
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Niruyadigutika etc., which are indicated in 
Madhumeha[1, 2, 3]. 
Recent research studies have reported that it has 
Antihyperglycemic, antioxidant activity[4], 
hypolipidemic, hepatoprotective[5] and cholinergic 
activity (Contraction of uterus). While going through 
article by name ‘Anti diabetic activity of roots of Salacia 
macrosperma’, by Venkateswarulu et.al. of Kakathiya 
University, showed that the methanolic fractions 
followed by the residual fractions of alcoholic extracts 
exhibited significant anti-diabetic activity [6]. 
The second drug Puga is mentioned in Vedas by 
the name Kramuka and in ancient Ayurvedic literature 
viz. Brihattrayi, Laghutrayi. There are many references 
in Ayurvedic literature where Puga is prescribed in 
Prameha, like  
 Susruta in Prameha Chikista advised to use 
Kadhira- Kramuka kasaya in the treatment of 
Madhumeha[7].  
 In Bhaishajya Ratnavali Kadara-Khadira-Puga 
Kvatha is advised in Kshoudrameha[8] and 
Cakradatta in Prameha rogadhikra [9]  
 Yogaratanara mentioned Pugapaka in 
Prameharogadhikara[10]. 
  Puga is mentioned in Salasaradi gana of Susruta 
Samhita and Asanadi gana of Astanga Hridayam, 
these are Ganas are indicated in Prameha and 
have Medo-Kaphahara karma as Kapha and Meda 
are the causative factors of Madhumeha[11,12]. 
Here the present study is undertaken to provide 
pharmacological basis and to support the clinical 
evidences and also to compare the efficacy of 
Saptacakra and Puga for pharmacological profiles and 
to ascertain whether administration of both Saptacakra 
and Puga in purified and raw form, singly or in 
combinations produces any adverse effects or not. 
Aim and objectives 
1. This study attempts to justify therapeutic 
application of the drugs used in AYUSH on the 
basis of efficacy and safety evaluation as per 
national and international norms. 
2. To study the effect of trail drugs (Saptacakra and 
Puga) on blood sugar level and histopathological 
studies on Alloxan induced Diabetic Winstar 
strain albino rats. 
3. To assures the efficacy of both Suddha Puga and 
Ashodita Puga as anti diabetic. 
MATERIAL AND METHODS 
A) Instruments used 
One touch Glucometer with Ez Smart strips, 
weighing scale, needle, syringe, Rat Feeding Needles 
(No.18 & 20), mono pan balance, oral feeding needle, 
rubber catheter, mortar & pestle, surgical instruments, 
refrigerator, sterilizer, pipette, glass slides and watch 
glass. 
B) The trail drugs 
The trail drugs taken for the studies are 
1. Ashodita Puga  
2. Suddha Puga 
3. Saptacakra 
Sharangadhara mentioned Kramuka as an 
example of Vikasi guna in the karma Paribhasha 
chapter [13]. After going through the different Nighantus, 
it was found that Vikasi, Ojonashaka property seen only 
in Apakva- Adrapuga[14,15] as it said to be Visha samana. 
Acharyas have indicated use of Puga in Madhumeha, 
which is one of the Vataja prameha manifestation due 
to Shaithilya abaddhatva of Dhatus and Ojas kshaya. 
 In Bhavaprakash Nighantu mentioned that Puga 
should be boiled in “Choughar”[16] (Decoction of 
Jambupatra and bark, Manjista Khadira sara, 
Raktachadana, Guda and Eranda taila) for Shodhana 
purpose. Most of the drugs used for Shodhana of Puga 
are of Kasaya rasa and Sita virya, which will pacify the 
Vikasi guna of Puga and potentiate the Puga gunas for 
the treatment of Madhumeha. So the Puga was purified 
in Choughar before using for treatment.  
The raw form of trail drugs Saptacakra and Puga 
were taken for the studies and were pounded to 
powder form in the department of Dravyaguna. 
Ashuddha Puga was purified in department of 
Rasashastra, T.T.D’s S.V.Ayurvedic College, Tirupati. 
C) Dose Selection [17] 
The dose selection plays vital role in animal 
studies, as it may sometimes increase mortality rate of 
rats.  
Rat dose- 450 mg/kg was fixed 
Here Rat dose = Human dose x 0.018 for 200gm rat 
weight. 
i.e. 5 gm x 0.018 = 0.09 gm or 90mg. 
Conversion to dose/kg body wt. = 90 X 5 = 450 mg/kg 
D) Preparation of drug for rat dose 
10 gms. of trail drug mixed in 100 ml of water and 
left over one night and next day morning it is filtered. 
From the filtrate 4.5 ml of aqueous solution is given to 
each rat (4.5 ml = 450 mg). 
E) Route of Drug Administration 
The trail drugs and vehicle to control were 
administered according to the body weight of the 
animals by oral route with the help of oral feeding 
needle. 
F) Animals 
Winstar strain albino rats of either sex, weighing 
between 170 – 280 g were obtained from the animal 
house attached to the Pharmacology Laboratory of Sree 
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Vidyanikkethan Pharmacy College, Tirupati. They were 
exposed to natural day and night cycles with ideal 
laboratory condition in terms of ambient temperature 
and humidity and fed with ad libitum of Amrut brand 
rat pellet feed supplied by Nava Maharashtra Chakan 
oil mills and tap water. 
EFFECT OF TRAIL DRUG IN THE ALLOXAN INDUCED 
DIABETIC RATS 
a). Induction of Diabetes: Winstar Rats were taken for 
the study and weighed, then alloxan monohydrate 
(Loba Chemie, Bombay) mixed in normal saline at the 
dose of 120 mg/kg was administered I.P. twice at the 
interval of 48 hrs to overnight fasted animals. After 96 
hrs of the 1st dose of alloxan, the glucose level was 
estimated. The rats with blood glucose level ranging 
between 250 mg/dl to 600 mg/dl were selected for the 
experimental study. 
b). Grouping: The diabetic rats were weighed, divided 
into five groups with 6 animals in each groups. The six 
animals were taken in each group to avoid death of 
animals after inducing diabetes by alloxan as it has high 
mortality rate (at least 3 to 4 rats may live, if remaining 
die). 
Group I:  Control group (NC) 
was given tap water only 
Group II :  
 
Diabetic control group (ALX) 
Diabetic induced rats by alloxan 
Dose – 5 ml/kg. 
Group III :  Ashodita Puga group (ALX + ACP) 
The aqueous solution of Ashodita Puga curna was given to alloxan induced diabetic rats. 
Dose – 450 mg/kg. 
Group VI : Saptacakra group (ALX + SRP) 
The aqueous solution of Saptacakra curna was given to alloxan induced diabetic rats. 
Dose – 450 mg/kg. 
Group V: Suddha Puga group (ALX + BACP) 
The aqueous solution of Suddha Puga was given to alloxan induced diabetic rats. 
Dose – 450 mg/kg. 
Group VI : Combination of Saptackara and Suddha Puga group 
(ALX + SRBACP) 
The aqueous solution of Combination of Saptackara and Suddha Puga curna was given 
to alloxan induced diabetic rats. 
Does – 450 mg/kg 
c). Procedure: Before one hour of administration of 
the drugs, the initial readings were taken by puncturing 
retro-orbital plexus under ether anaesthesia or cutting 
tail. After 15 days of treatment the blood glucose level 
were measured by collecting blood from tail or by 
puncturing retro orbital plexus method. The blood 
glucose level was measured by using one touch 
glucometer. 
BIOCHEMICAL ESTIMATIONS 
Blood sugar level and the serum lipid profiles such 
as total cholesterol, Phospholipids, triglycerides, LDL, 
V-LDL and HDL (Folch and Dunn, 1973; Burstein and 
Scholnick, 1972), investigations were carried out in 
normal and diabetic rats in the Bio-chemistry 
laboratory of Sree Vidhyaniketthan, Tirupati. 
STATISTICAL ANALYSIS 
All quantitative measurements were expressed as 
means ± SD for control and experimental animals. The 
data were analyzed using one way analysis of variance 
(ANOVA) on SPSS/PC (statistical package for social 
sciences, personal computer) and the group means 
were compared by Duncan’s Multiple Range Test 
(DMRT). The results were considered statistically 
significant if the p value was ≤ 0.05. 
OBSERVATIONS AND RESULTS 
Table 1: Effect of trail drugs on blood sugar level in all six groups 
Group Dose /kg. Blood sugar (mg/dl) Mean ± SEM % of  change 
B.T A.T 
Diabetic control 5 ml 289.50 ± 58.74 334.83 ±70.34 15.65 
ALX + ACP 450 mg/ kg 278.16 ± 47.72 248.33 ± 23.94 12.01 
ALX+ SRP 450 mg/kg 269.80 ± 32.18 221.40 ± 53.00 17.93** 
ALX+ BACP 450 mg/ kg 395.20 ± 82.52 329.34 ±105.16 16.66* 
ALX+ SRBACP 450 mg/ kg 423.60 ± 83.53 224.40 ± 53.39 47.02*** 
* P<0.05 ** P<0.01 *** P<0.001 
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Table 2: Effect of trail drugs on serum lipid profiles in ALX-induced diabetic and control rats 
Groups Total 
 cholesterol 
(mg/dl) 
Phospho- 
lipid (mg/dl) 
Tri- 
glycirides 
(mg/dl) 
HDL-C 
(mg/dl) 
VLDL-C 
(mg/dl) 
LDL-C 
(mg/dl) 
Diabetic 
control  
149.76± 
14.56 a 
196.75±  
20.35 a 
124.66±  
11.83 a 
16.76± 
1.90 a 
23.43± 
0.22 a 
97.76± 
0.94 a 
ALX+ACP 89.78 ± 
8.18b,* 
117.67±  
11.91 b,* 
63.22 ± 
5.98 b,* 
35.08 ± 
3.78b,* 
16.07 ± 
0.17b,* 
49.17 ± 
0.46b,* 
ALX+ SRP 
 
112.45± 
11.76 b,** 
149.09± 
 14.53 b,** 
77.44± 
6.99 b,* 
27.73± 
2.97b,* 
19.24± 
0.21 b,* 
71.16± 
0.71b,* 
ALX+ BACP 82.45± 
11.76 b,* 
117.09± 
 14.53 b,* 
62.44± 
6.99 b,* 
36.89± 
2.97b,* 
15.23± 
0.21b,* 
46.58± 
0.71b,* 
ALX+ 
SRBACP 
83.76 ± 
8.56 
118.52 ±  
10.77 
61.56± 
7.12 
36.98 ± 
3.87 
15.94 ± 
0.13 
48.32 ± 
0.43 
Values are mean ± SEM, n=6; ALX-alloxan a Alloxan induced diabetic group vs normal group,  
b trail drug treated group vs Alloxan induced diabetic group, #p <0.001; *p <0.05; **p<0.001. 
Assessment of hypoglycaemic activity by GTT in 
normal healthy rats:  
Glucose tolerance test is a standard procedure 
that addresses how quickly exogenous glucose can be 
cleared from blood. Specifically, uptake of glucose from 
the blood by cells is regulated by insulin. Impairment of 
glucose tolerance (i.e., longer time to clear given 
amount of glucose) indicates problems with 
maintenance of glucose homeostasis (insulin 
resistance, carbohydrate metabolism, diabetes, etc).  
Thirty six normal rats fasted overnight were 
divided in to six groups of six rats each were same as 
mentioned earlier expect that rats here are not induced 
Diabetes.  
Group III, IV, V, VI received single oral doses 
extract of drug powders suspended in distilled water. 
The blood samples were collected from the tail vein of 
these groups and blood glucose levels were estimated 
after 120 min of treatment. The Blood glucose level 
value at 120 min was treated as ‘0’min value for GTT. 
The animals were then orally administrated with 
2 g/kg of glucose and their glucose tolerance was 
studied at 15 mins, 30 mins, 60 mins, 90 mins and 120 
mins respectively, blood collected from the tail vein. 
The values are noted and statistically analysed. 
Table 3: Effect of trail drugs on oral glucose tolerance test (GTT) in normal rats 
Groups Serum glucose levels (mg/dl) 
 0 min 30 min 60 min 90 min 120 min 
Control 140.00 ± 17.43 a 
# 
184±  
1.71 a# 
258.60 ± 
45.38 a# 
156.60 ± 
18.43a# 
149.60± 
6.53a# 
Normal + 
glucose  
(2 g/kg) 
82.64 ± 1.78 241.86±  
1.35 
184.46 ± 
 1.71 
154.57 ±  
1.89 
90.34 ±  
1.49 
ACP + glucose  
(2 g/kg) 
83.68 ± 1.57 180.25±  
2.41 b * 
152.46 ±  
2.47 b * 
133.86 ± 
 1.42 b * 
91.78 ± 
 1.28 
SRP + glucose  
(2 g/kg) 
84.63 ± 1.83 161.65 ± 
1.47 b ** 
144.33 ± 
7.62 b ** 
124.68 ±  
1.49 b ** 
86.29 ±  
1.88 
BACP + glucose 
 (2 g/kg) 
83.29 ± 1.95 155.93 ± 2.81 b 
** 
148.06 ± 
3.84 b ** 
110.44 ± 
 2.53 b ** 
88.26 ±  
1.98 
SRBACP + 
glucose (2 g/kg) 
82.78 ± 1.22 173.25 ± 
1.47 b ** 
151.49 ± 
0.89 b ** 
131.26 ± 
 0.89 b ** 
87.59 ± 
 126 
Values are given as means  SEM for 6 rats in each group. anormal glucose group vs normal group,; b trail drug 
treated group vs normal glucose group,  #p <0.001 *p <0.05; **p<0.001 
Effect of trail drugs on histological findings of liver 
and pancreatic tissues 
The effect of the trail drugs on tissues of the 
Liver and pancreas of normal and diabetic rats were 
evaluated by histological studies of tissue sections 
obtained from the animals. On day 15 of the 
experiment, one animal was randomly selected from 
the different groups and sacrificed by over-dose of 
ether anaesthesia. The whole Liver and pancreas from 
each animal was removed and placed in 10% formalin 
in normal saline for histological studies and they were 
was placed in an automatic tissue processor for 24 hrs.  
 After 24 hrs, the tissues were solidified in 
molten wax and sectioned using automatic tissue 
sectioner. These tissue sections were then fixed on 
slides with haematoxylin and eosin and stained slides 
were fixed with mount, allowed to dry and viewed 
under the microscope (x400).  
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Table 4: Histopathological Changes in Liver 
  
 Control Group  
Histopathologically, liver structure and 
especially hepatocytes were in normal 
appearance and any degenerative, steatotic, 
fibrotic and inflammatory changes were not 
observed.  
  
Diabetic control Group 
Degenerative liver changes, characterized with 
very small intra cytoplasmic fat vacuoles at the 
periacinar and centrilobular areas, in various 
degrees were observed in alloxan treated 
group.  
  
ACP Group  
Degenerative liver changes, characterized with 
very small intra cytoplasmic fat vacuoles at the 
periacinar and centrilobular areas better than 
alloxan group. 
  
BACP Group 
In experimental groups, best liver conditions 
were seen in Ayurvedic formulation, with 
marked regeneration in mitochondria, nucleus 
and cytoplasmic structure in hepatocytes. 
   
SRP Group 
In experimental groups, best liver conditions 
were seen in Ayurvedic formulation. The 
mitochondrial structure in hepatocytes here 
seen normal. 
 
SRBACP Group 
In experimental groups, best liver conditions 
were seen in Ayurvedic formulation, with 
marked regeneration in mitochondria, nucleus 
and cytoplasmic structure in hepatocytes. 
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Table 5: Histopathological Changes in Pancreas 
  
Control Group 
The histology of pancreatic islet cells was 
normal in control group 
  
Diabetic Control Group 
In diabetic control group Histological 
examination of the pancreas shows the 
necrosis of the islet tissues with the alveolar 
cells moderately destroyed; there was also 
moderate congestion of the blood vessels.  
  
ACP Group 
In the group treated with ACP (450mg/kg.), 
the tissues of the pancreas appeared intact. 
The interlobular, intralobular and the alveolar 
granules were seen.  
  
BACP Group 
Group treatment with individual extracts of 
BACP (450mg/kg) showed initial regeneration 
of islets of langherans.  
  
SRP Group 
Group treatment with individual extracts of 
SRP (450mg/kg) showed initial regeneration 
of islets of langherans.  
  
SRBACP Group 
Group treatment with composite extracts of 
SRBACP (450mg/kg) in diabetic rats showed 
normal acini and islets that were comparable 
to that of normal control. 
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CONCLUSION
 The values mentioned under the word BT 
indicates initial blood sugar level after the injection of 
alloxan was given, the values increased 3 to 4 times than 
the normal blood sugar level. In control diabetic rats, 
after fifteen days of vehicle treatment, 15.65% increase in 
blood sugar level was observed. (Table- 1) 
 In Ashodita Puga group (ACP) 12.01% decrease 
in blood sugar was observed, it is not significant (p > 
0.05), whereas in Suddha Puga group (BACP) 16.66% 
lowering of blood sugar level was observed which is 
significant (p < 0.05) and Saptacakra group (SRP) 17.93% 
decrease which is very significant (p<0.01). In 
combination of both Saptacakra and Suddha Puga 
(SRBACP) 47.02% decrease in blood sugar level was 
observed, it is extremely significant (p< 0.001),though all 
the other groups show reduction in blood sugar level. 
Reduction in lipid profile was best noticed in BACP group; 
in particular reduction in triglycerides and improvement 
HDL was in combination group. (Table No- 1 and 2) 
  In oral glucose tolerance test, after 120 mins. the 
glucose level was reduced in all the groups, best seen in 
Saptacakra group (SRP) (Table No- 3). Best hepato 
protective action was observed in combination group, 
though Puga group also showed hepato protective 
activity and regeneration of islets of langherans was best 
seen in combination group. (Table No- 4 and 5) 
 Pharmacological experiments are always based 
on animal organs or tissues. As such it is not expected to 
find these experimental findings correlating with human 
therapeutics in exact manner. The action of a drug varies 
to a great extent on different animals becomes very 
apparent from the article “The evaluation of new drugs’ 
by Goodwin and Rose (Vide Pharma. Jour. Sept. 27 1951, 
Page 223). They said “It is hardly necessary to be 
reminded of the classical example of the rabbit, which can 
live on belladonna leaves, because it is insensitive to the 
poisonous effect of atropine”. They further say “It would 
not be satisfactory to use the rabbit alone as a guide to 
the safety of belladonna alkaloids in man”. 
Notwithstanding the above observation - basic 
pharmacology has important place in the study of drug. 
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Figure 1: Areca catechu plant Figure 2: Saptacakra plant 
 
 
Figure 3: Puga (Seeds of Areca catechu Linn.) Figure 4: Roots of Saptacakra 
 
 
Figure 4: Suddha Puga Curnam Figure 5: Saptacakra Curnam 
 
 
